Medicare Enrolled

Dr. Steven Ash, M.D.

Urology Physician · Grapevine, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
1601 LANCASTER DR STE 170, Grapevine, TX 76051
8174817727
In practice since 2006 (19 years)
NPI: 1326072299 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ash from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ash? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ash

Dr. Steven Ash is an urology physician in Grapevine, TX, with 19 years in practice. Based on federal Medicare data, Dr. Ash performed 4,051 Medicare services across 1,481 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ash received a total of $4,170 from 44 pharmaceutical and/or device companies across 199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ash is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 30% volume in TX$ $4,170 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,051
Medicare services
Top 30% in TX for urology physician
1,481
Unique beneficiaries
$41
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~213 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Infectious disease DNA/RNA test1,476$34$50
Urinalysis with microscopic exam430$3$15
Creatinine test (kidney function)430$5$20
Yeast/candida DNA test246$34$50
Office visit, established patient (30-39 min)144$98$269
Office visit, established patient, complex (40-54 min)144$138$370
Analysis for antibody to haemophilus influenza (respiratory bacteria)123$15$25
Detection test by nucleic acid for mycobacteria tuberculosis (tb bacteria), amplified probe technique123$40$50
Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique123$34$50
Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique123$34$50
Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique123$34$50
Hospital follow-up visit, high complexity105$94$250
Complete ultrasound scan of pelvis61$85$250
Office visit, established patient (20-29 min)59$67$193
Limited ultrasound scan behind abdominal cavity51$34$201
X-ray of abdomen, 1 view43$23$150
Initial hospital admission, high complexity33$136$421
Dilation of urethra using an endoscope31$264$1,010
Ultrasound scan of pelvic region through rectum28$111$340
New patient office visit, complex (60-74 min)26$163$453
Electronic assessment of bladder emptying24$6$30
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings23$26$325
Hospital follow-up visit, moderate complexity21$63$150
Other procedure on male genital system20$157$400
Drug injection, under skin or into muscle17$11$40
New patient office visit (45-59 min)13$123$362
Telephone medical discussion with physician, 21-30 minutes11$90$250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,170
Total received (2018-2024)
Avg $596/year across 7 years
Top 42% in TX for urology physician
44
Companies
199
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,824 (91.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$346 (8.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$279
2023
$777
2022
$484
2021
$942
2020
$695
2019
$552
2018
$440

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$635
Antares Pharma, Inc.
$516
Endo Pharmaceuticals Inc.
$425
Boston Scientific Corporation
$325
PFIZER INC.
$270
Myovant Sciences Inc.
$189
Blue Earth Diagnostics Limited
$133
Accord Healthcare, Inc.
$132
Alnylam Pharmaceuticals Inc.
$129
AbbVie Inc.
$112
ABBVIE INC.
$108
Clarus Therapeutics Inc.
$106
Janssen Biotech, Inc.
$95
AbbVie, Inc.
$72
Verity Pharmaceuticals Inc.
$70
IsoRay, Inc
$68
Coloplast Corp
$57
Axonics, Inc.
$55
BOSTON SCIENTIFIC CORPORATION
$54
NeoTract Inc.
$52
Kowa Pharmaceuticals America, Inc.
$49
Endo USA, Inc.
$48
Travere Therapeutics, Inc.
$38
Laborie Medical Technologies Corp.
$36
Merck Sharp & Dohme LLC
$32
Merck Sharp & Dohme Corporation
$30
Axonics Modulation Technologies, Inc.
$30
180 Medical, Inc.
$27
MEDIVATION FIELD SOLUTIONS LLC
$25
ConvaTec Inc.
$25
UroGen Pharma, Inc.
$23
Progenics Pharmaceuticals, Inc.
$21
Photocure Inc
$21
Olympus America Inc.
$21
Avation Medical, Inc.
$20
ACCORD HEALTHCARE, INC.
$17
Retrophin, Inc.
$17
Supernus Pharmaceuticals, Inc.
$16
Allergan, Inc.
$14
TOLMAR Pharmaceuticals, Inc.
$13
Zyla Life Sciences, Inc.
$13
Acerus Pharmaceuticals Corporation
$12
UROVANT SCIENCES INC
$12
Mission Pharmacal Company
$8
Top 3 companies account for 37.8% of total payments
Associated products mentioned in payments ›
(815) Thiola · AMS · AVEED · Androgel · Axonics · Axonics r-SNM System · Axumin · BOTOX · Brachytherapy Source · CAMCEVI · CYSVIEW · ELIGARD · ENDOUROLOGY · ERLEADA · Erleada · GEMTESA · GENERAL THERAPIES · GENERAL BPH · GENTLECATH · GREENLIGHT · General - Therapies · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · ORGOVYX · OTREXUP · OXLUMO · Otrexup · POSLUMA · PYLARIFY · REZUM · SEGLENTIS · SOLYX · SPRIX · SpeediCath · TOVIAZ · Thiola · Trelstar · URIBEL TABS · UroLift · Veozah · Vivally · XIAFLEX · XTANDI · XYOSTED · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $103 per 100 Medicare services performed
Looking for a urology physician in Grapevine?
Compare urology physicians in the Grapevine area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
180
Per 100K population
8.4
County median income
$81,905
Nearest hospital
BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ash is a mixed practice specialist, with above-average Medicare volume (top 30% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ash experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Ash performed 1,476 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ash receive payments from pharmaceutical companies?
Yes. Dr. Ash received a total of $4,170 from 44 companies across 199 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ash's costs compare to other urology physicians in Grapevine?
Dr. Ash's average Medicare payment per service is $41. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ash) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →